Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
JunD, not c-Jun, is the AP-1 transcription factor required for Ras-induced lung cancer
E. Josue Ruiz, Linxiang Lan, Markus Elmar Diefenbacher, Eva Madi Riising, Clive Da Costa, Atanu Chakraborty, Joerg D. Hoeck, Bradley Spencer-Dene, Gavin Kelly, Jean-Pierre David, Emma Nye, Julian Downward, Axel Behrens
E. Josue Ruiz, Linxiang Lan, Markus Elmar Diefenbacher, Eva Madi Riising, Clive Da Costa, Atanu Chakraborty, Joerg D. Hoeck, Bradley Spencer-Dene, Gavin Kelly, Jean-Pierre David, Emma Nye, Julian Downward, Axel Behrens
View: Text | PDF
Research Article Cell biology Oncology

JunD, not c-Jun, is the AP-1 transcription factor required for Ras-induced lung cancer

  • Text
  • PDF
Abstract

The AP-1 transcription factor c-Jun is required for Ras-driven tumorigenesis in many tissues and is considered as a classical proto-oncogene. To determine the requirement for c-Jun in a mouse model of K-RasG12D–induced lung adenocarcinoma, we inducibly deleted c-Jun in the adult lung. Surprisingly, we found that inactivation of c-Jun, or mutation of its JNK phosphorylation sites, actually increased lung tumor burden. Mechanistically, we found that protein levels of the Jun family member JunD were increased in the absence of c-Jun. In c-Jun–deficient cells, JunD phosphorylation was increased, and expression of a dominant-active JNKK2-JNK1 transgene further increased lung tumor formation. Strikingly, deletion of JunD completely abolished Ras-driven lung tumorigenesis. This work identifies JunD, not c-Jun, as the crucial substrate of JNK signaling and oncogene required for Ras-induced lung cancer.

Authors

E. Josue Ruiz, Linxiang Lan, Markus Elmar Diefenbacher, Eva Madi Riising, Clive Da Costa, Atanu Chakraborty, Joerg D. Hoeck, Bradley Spencer-Dene, Gavin Kelly, Jean-Pierre David, Emma Nye, Julian Downward, Axel Behrens

×

Figure 2

JunD phosphorylation is increased in c-Jun–null cells, which are more sensitive to JNK inhibition.

Options: View larger image (or click on image) Download as PowerPoint
JunD phosphorylation is increased in c-Jun–null cells, which are more se...
(A) Schematic representation of c-Junfl/fl; lsl-KRasG12D; p53fl/fl mouse model. Conditional c-Jun and p53 deletions and K-RasG12D expression in the lung was induced by intratracheal intubation (i.t.) with adenovirus carrying Cre recombinase (Adeno-Cre). (B) H&E, c-Jun, and phospho–c-JunSer73/phospho-JunDSer100 stains of lung tumors from mice of the indicated genotypes, 10 weeks after intubation. Scale bars: 2 mm (whole sections), 5 μm (inset). (C) Quantification of the tumor burden in whole lungs isolated from KP (3 mice/14 lobes) and JKP (3 mice/15 lobes) mice. Dots, individual lobes; red horizontal line, median. P values calculated using unpaired t test with Welch’s correction. (D) Violin plots quantifying the percentage of Ki67+ cells in lung tumors from mice of the indicated genotypes. KP (3 mice/60 tumors) and JKP (3 mice/85 tumors). Dots, individual lobes; red horizontal line, median. P values calculated using unpaired t test with Welch’s correction. (E) Lung tumor cells from KP and JKP mice were isolated and cultured in vitro. (F and G) Immunoblot analysis (F) and quantification (G) of KP and JKP cells probed for phospho–c-JunSer73/phospho-JunDSer100, JunD, and c-Jun. The results are expressed as mean ± SEM (n = 3 per group). Unpaired t test with Welch’s correction. (H) Relative mRNA expression of JUN and JUND in normal lung tissue (n = 5) and LADC (n = 9) patient samples measured by RT-PCR. Comparison of JUN and JUND mRNA expression between matched LADC patient samples. (I) Immunoblot analysis of KP and JKP cells with and without anisomycin and JNK inhibitor (SP600125) treatments. (J) KP and JKP cells were cultured with and without JNK inhibitor (SP600125), and proliferation was measured by counting the number of cells. Graph shows means ± SD; ****P < 0.0001, P values calculated using 2-way ANOVA with Tukey’s multiple-comparison test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts